170 related articles for article (PubMed ID: 8124686)
1. Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer.
Simons PJ; Oostendorp RA; Tas MP; Drexhage HA
Cancer Immunol Immunother; 1994 Mar; 38(3):178-84. PubMed ID: 8124686
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients.
Kerrebijn JD; Simons PJ; Tas M; Balm AJ; Drexhage HA
Eur Arch Otorhinolaryngol; 1995; 252(7):409-16. PubMed ID: 8562036
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive retroviral P15E-related factors in head and neck carcinomas.
Tan IB; Drexhage HA; Scheper RJ; von Blomberg-van de Flier BM; de Haan-Meulman M; Snow GB; Balm FJ
Arch Otolaryngol Head Neck Surg; 1986 Sep; 112(9):942-5. PubMed ID: 3741659
[TBL] [Abstract][Full Text] [Related]
4. Retroviral p15E-related serum factors and recurrence of head and neck cancer.
Tas MP; Laarman D; Haan-Meulman MD; Balm AJ; Snow GB; Drexhage HA
Clin Otolaryngol Allied Sci; 1993 Aug; 18(4):324-8. PubMed ID: 8877195
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive retroviral-related factors in sera of patients with head and neck cancer.
Tan IB; Balm AJ; Snow GB; Drexhage HA
Eur Arch Otorhinolaryngol; 1990; 247(6):387-90. PubMed ID: 2278707
[TBL] [Abstract][Full Text] [Related]
6. The presence of immunosuppressive 'p15E-like' factors in the serum and urine of patients suffering from malign and benign breast tumours.
Stöger H; Wilders-Truschnig M; Samonigg H; Schmid M; Bauernhofer T; Tiran A; Tas M; Drexhage HA
Clin Exp Immunol; 1993 Sep; 93(3):437-41. PubMed ID: 8370172
[TBL] [Abstract][Full Text] [Related]
7. Effects of tumor growth on host defenses.
Cianciolo GJ; Snyderman R
Cancer Metastasis Rev; 1986; 5(1):15-27. PubMed ID: 3524888
[TBL] [Abstract][Full Text] [Related]
8. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones.
Tas MP; Simons PJ; Balm FJ; Drexhage HA
Cancer Immunol Immunother; 1993; 36(2):108-14. PubMed ID: 8425208
[TBL] [Abstract][Full Text] [Related]
9. Distribution of retroviral p15E-related proteins in neoplastic and non-neoplastic human tissues, and their role in the regulation of the immune response.
Scheeren RA; Oostendorp RA; van der Baan S; Keehnen RM; Scheper RJ; Meijer CJ
Clin Exp Immunol; 1992 Jul; 89(1):94-9. PubMed ID: 1628428
[TBL] [Abstract][Full Text] [Related]
10. Effect of P15E related retroviral material isolated from head and neck carcinomas on delayed type hypersensitivity skin reactions in mice.
Tan IB; Drexhage HA; Scheper RJ; von Blomberg-van de Flier BM; dP6Haan-Meulman M; Snow GB; Balm FJ
Laryngoscope; 1987 Jun; 97(6):710-2. PubMed ID: 3586812
[TBL] [Abstract][Full Text] [Related]
11. Antiinflammatory proteins associated with human and murine neoplasms.
Cianciolo GJ
Biochim Biophys Acta; 1986 Aug; 865(1):69-82. PubMed ID: 3524686
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of retroviral-P15E-related material in carcinomas of the head and neck.
Tan IB; Drexhage HA; Mullink R; Hensen-Logmans S; De Haan-Meulman M; Snow GB; Balm AJ
Otolaryngol Head Neck Surg; 1987 Mar; 96(3):251-5. PubMed ID: 3108807
[TBL] [Abstract][Full Text] [Related]
13. New monoclonal antibodies against the putative immunosuppressive site of retroviral p15E.
Lang MS; Oostendorp RA; Simons PJ; Boersma W; Knegt P; van Ewijk W
Cancer Res; 1994 Apr; 54(7):1831-6. PubMed ID: 7511054
[TBL] [Abstract][Full Text] [Related]
14. Production of a retroviral P15E-related chemotaxis inhibitor by IL-1-treated endothelial cells. A possible negative feedback in the regulation of the vascular response to monokines.
Wang JM; Chen ZG; Cianciolo GJ; Snyderman R; Breviario F; Dejana E; Mantovani A
J Immunol; 1989 Mar; 142(6):2012-7. PubMed ID: 2537869
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy with monoclonal antibodies directed against the immunosuppressive domain of p15E inhibits tumour growth.
Lang MS; Hovenkamp E; Savelkoul HF; Knegt P; Van Ewijk W
Clin Exp Immunol; 1995 Dec; 102(3):468-75. PubMed ID: 8536359
[TBL] [Abstract][Full Text] [Related]
16. Identification of a decapeptide region of human interferon-alpha with antiproliferative activity and homology to an immunosuppressive sequence of the retroviral transmembrane protein P15E.
Ruegg CL; Strand M
J Interferon Res; 1990 Dec; 10(6):621-6. PubMed ID: 2086674
[TBL] [Abstract][Full Text] [Related]
17. Abnormal monocyte chemotaxis in patients with chronic purulent rhinosinusitis: an effect of retroviral p15E-related factors in serum.
van de Plassche-Boers EM; Tas M; de Haan-Meulman M; Kleingeld M; Drexhage HA
Clin Exp Immunol; 1988 Sep; 73(3):348-54. PubMed ID: 3264768
[TBL] [Abstract][Full Text] [Related]
18. Synthetic peptide homologous to the envelope proteins of retroviruses shares a cross-reacting epitope with the CD4 receptor.
Rothmann J; Hassan NF; Campbell DE; Kamani N; Douglas SD
J Clin Microbiol; 1990 Jan; 28(1):112-5. PubMed ID: 1688871
[TBL] [Abstract][Full Text] [Related]
19. A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815.
Belladonna ML; Fioretti MC; Bianchi R; Puccetti P; Grohmann U
Int J Immunopharmacol; 1996 Oct; 18(10):563-76. PubMed ID: 9080250
[TBL] [Abstract][Full Text] [Related]
20. Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E.
Cianciolo GJ; Lostrom ME; Tam M; Snyderman R
J Exp Med; 1983 Sep; 158(3):885-900. PubMed ID: 6193238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
